Related Experiment Video
Updated: Mar 28, 2026
08:59
Method of Isolated Ex Vivo Lung Perfusion in a Rat Model: Lessons Learned from Developing a Rat EVLP Program
Published on: February 25, 2015
29.0K
The evolving potential for pediatric ex vivo lung perfusion
Jessica G Y Luc1,2, Jayan Nagendran1,2,3,4
1Division of Cardiac Surgery, Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
Pediatric Transplantation
|December 24, 2015
Summary
Ex vivo lung perfusion (EVLP) can help address the donor organ shortage for pediatric lung transplants. This technique improves donor lung assessment and utilization, potentially increasing transplants for children and adolescents.
Area of Science:
- Thoracic Surgery
- Transplantation Medicine
- Pediatric Pulmonology
Background:
- Pediatric lung transplantation rates remain low despite increased adult procedures.
- Donor organ shortage is a significant limitation for pediatric lung transplants.
- Lung transplantation is a vital therapy for pediatric end-stage lung disease.
Purpose of the Study:
- To explore the role of ex vivo lung perfusion (EVLP) in pediatric lung transplantation.
- To assess EVLP's potential to overcome donor organ shortages in pediatric patients.
- To evaluate EVLP's impact on the quality and outcomes of pediatric lung transplants.
Main Methods:
- Review of EVLP adoption in adult lung transplantation.
- Discussion of EVLP's application in donor lung assessment and preservation.
- Analysis of potential EVLP utilization for pediatric recipients.
Main Results:
- EVLP has successfully increased adult lung transplantations and donor lung utilization.
- EVLP serves as a platform for evaluating and preserving donor lung function.
- The technique shows promise for expanding donor pool availability.
Conclusions:
- EVLP has the potential to significantly improve pediatric lung transplantation outcomes.
- Wider adoption of EVLP could overcome donor shortages in pediatric patients.
- Further research into EVLP for pediatric use is warranted to enhance lung graft utilization.
